LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 90 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $264,000 | -25.2% | 104,841 | -15.3% | 0.07% | -25.3% |
| Q2 2021 | $353,000 | +29.8% | 123,730 | +6.9% | 0.09% | -2.2% |
| Q1 2021 | $272,000 | -9.3% | 115,730 | -32.2% | 0.09% | +47.6% |
| Q4 2020 | $300,000 | +141.9% | 170,658 | +28.6% | 0.06% | +14.5% |
| Q3 2020 | $124,000 | +19.2% | 132,668 | +10.9% | 0.06% | +1.9% |
| Q2 2020 | $104,000 | +16.9% | 119,629 | +11.4% | 0.05% | -6.9% |
| Q1 2020 | $89,000 | +229.6% | 107,379 | +259.7% | 0.06% | +241.2% |
| Q4 2019 | $27,000 | – | 29,853 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,005,379 | $83,313,000 | 5.12% |
| Defender Capital, LLC. | 4,997,870 | $12,245,000 | 3.92% |
| Raffles Associates | 543,590 | $1,332,000 | 1.28% |
| Prescott General Partners LLC | 1,851,851 | $4,537,000 | 0.16% |
| DCF Advisers, LLC | 85,000 | $208,000 | 0.08% |
| Long Focus Capital Management, LLC | 215,000 | $527,000 | 0.07% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $110,000 | 0.06% |
| DAFNA Capital Management LLC | 80,000 | $196,000 | 0.05% |
| Strategic Wealth Investment Group, LLC | 65,069 | $159,000 | 0.04% |
| Fort Sheridan Advisors LLC | 52,931 | $130,000 | 0.04% |